Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "United-Biotechnology"

1 News Found

Novo Nordisk’s
Clinical Trials | February 24, 2026

Novo Nordisk’s "Triple G" drug UBT251 triggers nearly 20% weight loss in 24 weeks

UBT251 appeared to have a safe and well-tolerated profile consistent with incretin-based therapies